SCHEMBL21671863

SCHEMBL21671863

CN1CCC(n2ccc3cc(N)cnc32)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 2/20 0.41
AURKA O14965 3/20 0.40
CDK1 P06493 2/20 0.40
CDK4 P11802 2/20 0.40
INSR P06213 1/20 0.40
PDGFRB P09619 1/20 0.40
SRC P12931 1/20 0.40
PDGFRA P16234 1/20 0.40
FLT1 P17948 1/20 0.40
FLT4 P35916 1/20 0.40
KDR P35968 1/20 0.40
CDK7 P50613 1/20 0.40
NTRK2 Q16620 1/20 0.40
GAA P10253 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALOX15 P16050 1/20 0.38
AURKB Q96GD4 1/20 0.37
CHEK1 O14757 1/20 0.37
CHEK2 O96017 1/20 0.37
NOS3 P29474 6/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31403529 0.85 DGAT1 (0.48) DGAT1AURKACDK1CDK4INSR
SCHEMBL21641739 0.85 MAPK14 (0.39) DGAT1AURKACDK1CDK4INSR
SCHEMBL31403695 0.79 KDM2B (0.46) DGAT1AURKACDK1CDK4INSR
SCHEMBL31403646 0.78 DGAT1 (0.50) DGAT1AURKACDK4
SCHEMBL22743595 0.78 AURKA (0.41) DGAT1AURKACDK1CDK4INSR
SCHEMBL31403618 0.76 HTR1A (0.43) AURKACDK1CDK4INSRPDGFRB
SCHEMBL30594683 0.75 PRKCI (0.51) DGAT1GAASMN1; SMN2NOS3NOS1
SCHEMBL2266494 0.75 PRKCI (0.51) DGAT1GAASMN1; SMN2NOS3NOS1
SCHEMBL18379156 0.73 CCR1 (0.40) DGAT1AURKACDK1CDK4INSR
SCHEMBL3352865 0.72 HTR1D (0.51) GAASMN1; SMN2NOS3NOS1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3604306-A1 MACROCYCLIC DERIVATIVE OF PYRAZOL[3,4-D]PYRIMIDIN-3-ONE, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai de Novo Pharmatech Co., Ltd. (CN) 2020-02-05 EP disclosed